ÂÜÀòÂÒÂ×

The Clinical Development Team at Lytix Biopharma is responsible for planning and executing clinical trials to evaluate the safety and efficacy of the company’s oncolytic peptide therapies. This team collaborates across various functions, including regulatory compliance and manufacturing, to ensure seamless progression from preclinical research to clinical applications. They play a crucial role in advancing innovative cancer treatments, ultimately aiming to bring new therapeutic options to patients.